Clinical course of penile fibrosis in intracavernosal prostaglandin E1 injection therapy: A follow-up of 44 patients

International Journal of Impotence Research

Volumn 15, Issue 2, 2003, Pages 94-98

  Chew, K K ^a,b   Stuckey, B G A ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Fibrotic changes in penis; Intracavernosal injection; Penile fibrosis; Prostaglandin E1; Spontaneous improvement

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGED; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE COURSE; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; MALE; OUTCOMES RESEARCH; PAIN; PENILE FIBROSIS; PENILE PAIN; PENIS; PENIS CURVATURE; PRIORITY JOURNAL; REVIEW;

ADULT; AGED; ALPROSTADIL; FIBRINOLYTIC AGENTS; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PENIS; TREATMENT OUTCOME;

EID: 0038577135     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900951     Document Type: Review

References (10)

1. Chew KK. Intracavernosal injection therapy: does it still have a role in erectile dysfunction. Aust Fam Physician 2001; 30: 43-46.
2. Lakin MM, Montague DK, Schover LR. Fibrosis with intracavernous injection therapy utilizing prostaglandin E1. J Ural 1992; 147: 309A.
3. Porst H. Experience with alprostadil in diagnosis and therapy in Germany. In: Proceedings of Symposium on The Role of Alprostadil in the Diagnosis and Treatment of Erectile Dysfunction. Goldstein I, Lye TF Excerta Medica Inc.: Princeton, 1993, pp 142-154.
4. Linet OI, Ogrinc FG. Long-term Safety Study with Alprostadil Sterile Powder in Patients with Erectile Dysfunction. The Upjohn Co. Technical Report, 1993.
5. Stackl W, Hasun R, Hammar C. Peyronie's disease induced by intracavernous injection of prostaglandin E1. Int J Impot Res 1994; 6(Suppl 1): D30.
6. Chen RN, Lakin MM, Montague DK, Ausmundson S. Penile scarring with intracavernous injection therapy using prostaglandin El: a risk factor analysis. J Urol 1996; 155: 138-140.
7. Mumtaz FH et al. Prostaglandin E1 intracavernmosal injections - longterm results and complications. Int J Impot Res 1996; 7: 120.
8. Chew KK et al. Penile fibrosis in intracavernmosal prostaglandin E1 injection therapy for erectile dysfunction. Int J Impot Res. 1997; 9: 225-229.
9. Linet OI, Ogrinc FG. Penile fibrosis during 18 months of intracavernosal therapy with alprostadil. Int J Impot Res 1996; 8: 143.
10. Porst H et al. Final results of a prospective multicentre study with self-injection therapy with PGE1 after 4y of follow-up. Int J Impot Res 1996; 8: 151.